Turing Pharmaceuticals

Listing Websites about Turing Pharmaceuticals

Filter Type:

Turing Pharmaceuticals

(2 days ago) Oops! Something went wrong, please try again later.Add hoursAdd photosOops! Something went wrong, please try again later.WebsiteDirectionsContact usOops! Something went wrong, please try again later.Suggest an edit · Your business? Claim nowTuring Pharmaceuticals: a glimpse into controversial drug …https://ecampusontario.pressbooks.pub/bio16610w18Turing Pharmaceuticals was a Swiss-incorporated company founded on the 24th of February 2015 by Martin Shkreli. Their first acquisitions were from Retrophin (a company previously founded by Shkreli): an intranasal formulation of ketamine, an oxytocin nasal solution, and Vecamyl. During the same year (August 5th)… See more

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Turing Pharmaceuticals - Crunchbase Company Profile

(2 days ago) WebTuring Pharmaceuticals is a biopharmaceutical company focusing on patients with unmet medical needs. The company is dedicated to helping …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Turing Pharmaceuticals CEO Martin Shkreli Arrested for Securities …

(4 days ago) Web— -- Turing Pharmaceuticals CEO and former hedge fund manager Martin Shkreli, who was heavily criticized for raising the price of a drug used to treat a life …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


A Timeline of the Turing Pharma Controversy - Forbes

(8 days ago) WebFeb. 24 —Turing Pharma announces it is officially in business. It acquired three products--an intranasal formulation of ketamine, oxytocin nasal solution, and mecamylamine …

Url: Visit Now

Category:  Health Detail Drugs


Vyera Pharmaceuticals - Wikipedia

(1 days ago) Vyera Pharmaceuticals (formerly Turing Pharmaceuticals) is a pharmaceutical company incorporated in Zug, Switzerland, with offices in New York City. The company started to do business in the US as Vyera Pharmaceuticals in September 2017. The company has two marketed products: Daraprim (pyrimethamine), for the t…

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Turing Pharmaceuticals AG LinkedIn

(5 days ago) WebTuring Pharmaceuticals AG is a privately-held biopharmaceutical company with offices in New York City and Zug, Switzerland. Turing focuses on developing and commercializing innovative treatments

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Turing Pharmaceuticals: The Ethics of Drug Pricing [8 …

(7 days ago) WebStep 1 - Establish a sense of urgency. What are areas that require urgent change management efforts in the “ Turing Pharmaceuticals: The Ethics of Drug Pricing “ case …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Ethical Violations and turing pharmaceuticals

(5 days ago) WebTuring Pharmaceuticals is a corporation, based in Zug, Switzerland. The company was launched in February 2015 by Shkreli Martin where he acquired three primary assets …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


'Pharma Bro' Martin Shkreli fined $64M, banned from …

(2 days ago) WebIn 2015,Shkreli’s company, Turing Pharmaceuticals, acquired the rights to Daraprim, a life-saving drug that is used to treat infections that occur in patients suffering …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Vyera Pharmaceuticals

(2 days ago) WebVyera Pharmaceuticals is committed to developing and commercializing treatments that address serious and neglected diseases with high unmet medical needs. Read More. Research & Development. Vyera is focused …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Working at Turing Pharmaceuticals: Employee Reviews Indeed.com

(7 days ago) WebTuring was initially a highly dynamic and positive organization whose culture was more like a silicon valley start up than a pharma company. Also many of my co-workers where …

Url: Visit Now

Category:  Health Detail Drugs


Turing Pharmaceuticals - Funding, Financials, Valuation & Investors

(1 days ago) WebFunding. Turing Pharmaceuticals has raised a total of $90M in funding over 1 round. This was a Series A round raised on Aug 10, 2015. Turing Pharmaceuticals is …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Turing Pharmaceuticals Launches - Drug Discovery and …

(8 days ago) WebTuring Pharmaceuticals AG announced its official launch, along with news of three acquisitions for its commercial operations and development pipeline. Turing’s …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Turing Pharmaceuticals: The Ethics of Drug Pricing Case Study …

(9 days ago) WebThe Turing Pharmaceuticals: The Ethics of Drug Pricing (referred as “Turing Daraprim” from here on) case study provides evaluation & decision scenario in field of Leadership & …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Turing Pharmaceuticals: The Ethics of Drug Pricing - HBR Store

(6 days ago) WebIn 2015 there was a public outcry over the price increase in Daraprim (pyrimethamine) by Turing Pharmaceuticals AG (Turing). Daraprim was a drug that was widely used by a …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Turing Pharmaceuticals Careers and Employment Indeed.com

(9 days ago) WebFind out what works well at Turing Pharmaceuticals from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Turing Pharmaceuticals C.E.O.: We’ll Maybe Stop the Drug Price …

(3 days ago) WebAs The New York Times reported on Sunday, Turing raised the price of the 62-year-old drug Daraprim to $750 a tablet from $13.50 overnight, after buying it in August.

Url: Visit Now

Category:  Health Detail Drugs


Turing - Hire Remote Developers Top 1% of 2 Million+ Software …

(3 days ago) WebTuring.com - Hire remote developers World's most deeply vetted software engineers Remote U.S. developer jobs Full-stack, mobile, frontend, DevOps, AI/ML.

Url: Visit Now

Category:  Health Detail Drugs


US pharmaceutical company defends 5,000% price increase

(9 days ago) Web22 September 2015. Turing Pharmaceuticals boss Martin Shkreli had previously defended the price raise. The head of a US pharmaceutical company has …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs

Popular Searched

 › United healthcare over the counter catalog 2022

 › Uv lights health effects

 › Recent medicare fraud cases

 › Drug court handbook pdf

 › Gnc quick flush drug test

 › Health insurance retirement options

 › United states medical licensing board

 › Home caregiver resume examples

 › Dea drug take back day

 › Hospice community care of texas

Recently Searched

 › Reasonable suspicion drug test checklist

 › Aetna medicare home care agencies

 › Humana medicare coverage guidelines

 › Cms medicaid drug rebate

 › Lsu school of vet medicine

 › Cost of prescription drugs 2020

 › Pharmacy benefit manager legislation

 › Medicare cms drug pricing

 › Coastal medical supply savannah ga

 › Campbell pharmacy school requirements

FAQ about Turing Pharmaceuticals

What does Turing Pharmaceuticals stand for?

Vyera Pharmaceuticals (formerly Turing Pharmaceuticals) is a pharmaceutical company incorporated in Zug, Switzerland, with offices in New York City. The company started to do business in the US as Vyera Pharmaceuticals in September 2017.

Why did Turing raise the price of a drug?

Soon after Turing acquired its commercialization rights in August 2015, the company increased the list price of the drug by over 5,000 per cent. The increase led to consumer protests in the United States, and the media vehemently condemned Turing's action of raising the price for the decades-old drug that had gone off-patent in 1970.

What is Turing Pharmaceuticals boss Martin Shkreli's position on Daraprim?

Media captionTuring Pharmaceuticals boss Martin Shkreli had previously defended the price raise. The head of a US pharmaceutical company has defended his company's decision to raise the price of a 62-year-old medication used by Aids patients by over 5,000%. Turing Pharmaceuticals acquired the rights to Daraprim in August.

Did Turing lower the price of Martin Shkreli’s drug?

After two days of nonstop outrage, Shkreli went on ABC’s World News Tonight on Tuesday to say that Turing has agreed to lower the price of the drug to something that’s “more affordable” while still allowing the company to make a profit. He said he’s not quite sure where that new, lower price will end up.